The team, led by Erik Larson, PhD, published results explaining how Autosomal Dominant Polycystic Kidney Disease (ADPKD ... broader implications for tumor prevention, research officials said.

Autosomal Dominant Polycystic Kidney Disease (ADPKD) affects one out of every 400 to 1,000 people, according to the release. Though the disease affects multiple parts of the body, the most notable ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...